Greece

Greece

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.1 2017 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
1.8 (1.65 - 1.97) 2019 Modelled IHME
1.8 (1.65 - 1.96) 2018 Modelled IHME
1.81 (1.63 - 1.97) 2017 Modelled IHME
1.81 (1.64 - 1.97) 2016 Modelled IHME
1.81 (1.64 - 2) 2015 Modelled IHME
1.82 (1.65 - 2) 2014 Modelled IHME
1.83 (1.67 - 2.01) 2013 Modelled IHME
1.84 (1.68 - 2.02) 2012 Modelled IHME
1.86 (1.69 - 2.04) 2011 Modelled IHME
1.87 (1.71 - 2.06) 2010 Modelled IHME
1.89 (1.73 - 2.07) 2009 Modelled IHME
1.91 (1.75 - 2.09) 2008 Modelled IHME
1.93 (1.77 - 2.10) 2007 Modelled IHME
1.95 (1.77 - 2.13) 2006 Modelled IHME
1.97 (1.78 - 2.16) 2005 Modelled IHME
1.99 (1.81 - 2.18) 2004 Modelled IHME
2.01 (1.83 - 2.20) 2003 Modelled IHME
2.03 (1.85 - 2.21) 2002 Modelled IHME
2.04 (1.87 - 2.24) 2001 Modelled IHME
2.06 (1.88 - 2.27) 2000 Modelled IHME
2.08 (1.90 - 2.28) 1999 Modelled IHME
2.1 (1.92 - 2.30) 1998 Modelled IHME
2.12 (1.94 - 2.33) 1997 Modelled IHME
2.14 (1.95 - 2.35) 1996 Modelled IHME
2.15 (1.95 - 2.37) 1995 Modelled IHME
2.17 (1.97 - 2.38) 1994 Modelled IHME
2.18 (1.98 - 2.40) 1993 Modelled IHME
2.2 (2 - 2.42) 1992 Modelled IHME
2.21 (2.01 - 2.44) 1991 Modelled IHME
2.22 (2.01 - 2.47) 1990 Modelled IHME
3.3 (2.20 - 4.70) 2010 Modelled Drositis I et al, 2013
1.14 (0.91 - 1.46) 2015 Modelled WHO
1.8 (1.50 - 2) 2016 Modelled Razavi-Shearer et al, 2018
0.97 (0.95 - 1) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.05 (0.04 - 0.07) 2019 Modelled IHME
0.05 (0.04 - 0.07) 2018 Modelled IHME
0.05 (0.04 - 0.07) 2017 Modelled IHME
0.05 (0.04 - 0.07) 2016 Modelled IHME
0.05 (0.04 - 0.07) 2015 Modelled IHME
0.05 (0.04 - 0.07) 2014 Modelled IHME
0.05 (0.04 - 0.07) 2013 Modelled IHME
0.06 (0.04 - 0.07) 2012 Modelled IHME
0.06 (0.04 - 0.07) 2011 Modelled IHME
0.06 (0.04 - 0.08) 2010 Modelled IHME
0.06 (0.04 - 0.08) 2009 Modelled IHME
0.06 (0.05 - 0.08) 2008 Modelled IHME
0.07 (0.05 - 0.09) 2007 Modelled IHME
0.07 (0.05 - 0.09) 2006 Modelled IHME
0.07 (0.05 - 0.10) 2005 Modelled IHME
0.08 (0.06 - 0.10) 2004 Modelled IHME
0.08 (0.06 - 0.11) 2003 Modelled IHME
0.09 (0.07 - 0.12) 2002 Modelled IHME
0.1 (0.07 - 0.13) 2001 Modelled IHME
0.11 (0.09 - 0.14) 2000 Modelled IHME
0.18 (0.14 - 0.23) 1999 Modelled IHME
0.32 (0.25 - 0.42) 1998 Modelled IHME
0.49 (0.38 - 0.64) 1997 Modelled IHME
0.63 (0.49 - 0.82) 1996 Modelled IHME
0.71 (0.54 - 0.94) 1995 Modelled IHME
0.73 (0.55 - 0.96) 1994 Modelled IHME
0.75 (0.56 - 1) 1993 Modelled IHME
0.77 (0.57 - 1.02) 1992 Modelled IHME
0.78 (0.57 - 1.04) 1991 Modelled IHME
0.78 (0.57 - 1.05) 1990 Modelled IHME
0.37 (0.25 - 0.52) 2015 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
2.1 2017 Survey/reported ECDC
1.6 2016 Survey/reported EMCDDA
2.81 2015 Survey/reported EMCDDA
3.19 2014 Survey/reported EMCDDA
3.54 2013 Survey/reported EMCDDA
2.73 2012 Survey/reported EMCDDA
2.85 2015 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.75 2014 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.48 2013 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.27 2012 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.84 2011 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.89 2010 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.25 2009 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.71 2008 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.56 2006 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.34 2005 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.43 2004 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
2.33 2003 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
3.3 2002 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
4.3 2001 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) & University Mental Health Research Institute (UMHRI)
1.67 2015 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
1.88 2014 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
2.01 2013 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
1.32 2012 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
1.18 2011 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
3.64 2010 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
2.99 2009 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
2.26 2008 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
1.72 2006 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
3.09 2005 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
2.69 2004 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
5.84 2003 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
6.9 2002 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
4.8 2001 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
3.8 2000 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
3.5 1999 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
2.9 (2.40 - 3.50) 2003 Survey/reported Papaevangelou V et al, 2006
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
230,936 (208,801 - 256,741) 1990 Modelled IHME
231,267 (209,844 - 255,458) 1991 Modelled IHME
232,143 (210,854 - 255,826) 1992 Modelled IHME
232,539 (211,329 - 255,819) 1993 Modelled IHME
232,622 (211,544 - 255,678) 1994 Modelled IHME
232,503 (210,109 - 255,914) 1995 Modelled IHME
232,164 (211,695 - 255,128) 1996 Modelled IHME
231,685 (211,784 - 254,136) 1997 Modelled IHME
231,131 (210,801 - 253,494) 1998 Modelled IHME
230,044 (210,186 - 252,186) 1999 Modelled IHME
228,879 (208,513 - 251,696) 2000 Modelled IHME
227,770 (208,185 - 249,305) 2001 Modelled IHME
226,072 (206,161 - 247,162) 2002 Modelled IHME
223,935 (204,265 - 245,318) 2003 Modelled IHME
221,717 (201,783 - 243,205) 2004 Modelled IHME
219,547 (198,114 - 241,014) 2005 Modelled IHME
217,267 (197,831 - 237,620) 2006 Modelled IHME
214,807 (196,867 - 234,425) 2007 Modelled IHME
212,393 (194,882 - 232,376) 2008 Modelled IHME
210,062 (192,636 - 230,214) 2009 Modelled IHME
207,673 (188,965 - 228,397) 2010 Modelled IHME
204,844 (186,629 - 224,419) 2011 Modelled IHME
201,301 (183,553 - 220,482) 2012 Modelled IHME
197,648 (180,026 - 216,499) 2013 Modelled IHME
194,524 (176,635 - 213,575) 2014 Modelled IHME
191,990 (173,372 - 211,533) 2015 Modelled IHME
190,231 (172,952 - 207,097) 2016 Modelled IHME
188,943 (170,375 - 205,909) 2017 Modelled IHME
187,532 (172,093 - 203,806) 2018 Modelled IHME
185,964 (170,082 - 203,812) 2019 Modelled IHME
200,000 (168,000 - 222,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.6 (2.89 - 4.48) 2019 Modelled IHME
3.59 (2.89 - 4.42) 2018 Modelled IHME
3.56 (2.87 - 4.40) 2017 Modelled IHME
3.55 (2.83 - 4.34) 2016 Modelled IHME
3.5 (2.79 - 4.29) 2015 Modelled IHME
3.5 (2.80 - 4.27) 2014 Modelled IHME
3.67 (2.98 - 4.45) 2013 Modelled IHME
3.65 (2.99 - 4.39) 2012 Modelled IHME
3.53 (2.90 - 4.25) 2011 Modelled IHME
3.37 (2.76 - 4.03) 2010 Modelled IHME
3.3 (2.70 - 3.93) 2009 Modelled IHME
3.25 (2.64 - 3.90) 2008 Modelled IHME
3.42 (2.80 - 4.13) 2007 Modelled IHME
3.37 (2.72 - 4.10) 2006 Modelled IHME
3.33 (2.68 - 4.07) 2005 Modelled IHME
3.23 (2.60 - 3.95) 2004 Modelled IHME
3.21 (2.58 - 3.91) 2003 Modelled IHME
3.17 (2.56 - 3.87) 2002 Modelled IHME
3.17 (2.54 - 3.89) 2001 Modelled IHME
3.18 (2.54 - 3.89) 2000 Modelled IHME
3.18 (2.55 - 3.91) 1999 Modelled IHME
3.14 (2.53 - 3.86) 1998 Modelled IHME
3.1 (2.48 - 3.82) 1997 Modelled IHME
3.11 (2.49 - 3.83) 1996 Modelled IHME
3.12 (2.50 - 3.85) 1995 Modelled IHME
3.13 (2.47 - 3.88) 1994 Modelled IHME
3.14 (2.48 - 3.91) 1993 Modelled IHME
3.17 (2.51 - 3.95) 1992 Modelled IHME
3.13 (2.47 - 3.91) 1991 Modelled IHME
3.11 (2.43 - 3.91) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
372 (299 - 463) 2019 Modelled IHME
374 (300 - 460) 2018 Modelled IHME
373 (300 - 460) 2017 Modelled IHME
373 (297 - 457) 2016 Modelled IHME
370 (296 - 455) 2015 Modelled IHME
374 (299 - 457) 2014 Modelled IHME
396 (322 - 481) 2013 Modelled IHME
398 (326 - 479) 2012 Modelled IHME
389 (320 - 468) 2011 Modelled IHME
373 (306 - 447) 2010 Modelled IHME
366 (300 - 437) 2009 Modelled IHME
361 (294 - 434) 2008 Modelled IHME
381 (312 - 460) 2007 Modelled IHME
376 (303 - 457) 2006 Modelled IHME
372 (299 - 455) 2005 Modelled IHME
361 (290 - 440) 2004 Modelled IHME
358 (288 - 436) 2003 Modelled IHME
354 (286 - 432) 2002 Modelled IHME
353 (283 - 433) 2001 Modelled IHME
353 (281 - 432) 2000 Modelled IHME
352 (281 - 432) 1999 Modelled IHME
346 (278 - 425) 1998 Modelled IHME
338 (271 - 418) 1997 Modelled IHME
338 (270 - 416) 1996 Modelled IHME
337 (270 - 416) 1995 Modelled IHME
335 (265 - 416) 1994 Modelled IHME
335 (264 - 416) 1993 Modelled IHME
334 (265 - 417) 1992 Modelled IHME
327 (258 - 409) 1991 Modelled IHME
324 (253 - 406) 1990 Modelled IHME
967 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
32 (24 - 42) 2019 Modelled IHME
32 (24 - 42) 2018 Modelled IHME
32 (24 - 42) 2017 Modelled IHME
32 (24 - 42) 2016 Modelled IHME
32 (24 - 42) 2015 Modelled IHME
32 (24 - 42) 2014 Modelled IHME
32 (24 - 43) 2013 Modelled IHME
32 (24 - 42) 2012 Modelled IHME
32 (24 - 42) 2011 Modelled IHME
32 (24 - 42) 2010 Modelled IHME
32 (24 - 42) 2009 Modelled IHME
32 (24 - 42) 2008 Modelled IHME
33 (24 - 43) 2007 Modelled IHME
34 (25 - 44) 2006 Modelled IHME
34 (25 - 44) 2005 Modelled IHME
34 (25 - 44) 2004 Modelled IHME
34 (25 - 44) 2003 Modelled IHME
34 (25 - 44) 2002 Modelled IHME
34 (25 - 44) 2001 Modelled IHME
34 (25 - 44) 2000 Modelled IHME
34 (25 - 44) 1999 Modelled IHME
34 (25 - 44) 1998 Modelled IHME
34 (25 - 44) 1997 Modelled IHME
34 (25 - 44) 1996 Modelled IHME
34 (25 - 44) 1995 Modelled IHME
34 (25 - 44) 1994 Modelled IHME
34 (25 - 43) 1993 Modelled IHME
34 (25 - 43) 1992 Modelled IHME
34 (25 - 43) 1991 Modelled IHME
34 (25 - 43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2019 Survey/reported WHO/UNICEF
96 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
76 2017 Survey/reported EMCDDA, 2019
53 (43 - 65) 2014 Survey/reported Reitox National Focal Point, 2014
76 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
65 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
NSP in at least one prison
No
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.61 (0.50 - 0.75) 2019 Modelled IHME
0.61 (0.50 - 0.74) 2018 Modelled IHME
0.6 (0.49 - 0.74) 2017 Modelled IHME
0.59 (0.49 - 0.73) 2016 Modelled IHME
0.58 (0.47 - 0.72) 2015 Modelled IHME
0.57 (0.47 - 0.71) 2014 Modelled IHME
0.57 (0.47 - 0.70) 2013 Modelled IHME
0.56 (0.46 - 0.69) 2012 Modelled IHME
0.56 (0.46 - 0.69) 2011 Modelled IHME
0.56 (0.46 - 0.68) 2010 Modelled IHME
0.55 (0.45 - 0.68) 2009 Modelled IHME
0.55 (0.45 - 0.68) 2008 Modelled IHME
0.55 (0.45 - 0.68) 2007 Modelled IHME
0.54 (0.44 - 0.68) 2006 Modelled IHME
0.54 (0.44 - 0.67) 2005 Modelled IHME
0.52 (0.43 - 0.64) 2004 Modelled IHME
0.48 (0.40 - 0.59) 2003 Modelled IHME
0.44 (0.36 - 0.54) 2002 Modelled IHME
0.41 (0.34 - 0.49) 2001 Modelled IHME
0.39 (0.32 - 0.48) 2000 Modelled IHME
0.39 (0.32 - 0.47) 1999 Modelled IHME
0.4 (0.33 - 0.47) 1998 Modelled IHME
0.4 (0.33 - 0.48) 1997 Modelled IHME
0.4 (0.33 - 0.48) 1996 Modelled IHME
0.41 (0.34 - 0.49) 1995 Modelled IHME
0.42 (0.35 - 0.50) 1994 Modelled IHME
0.45 (0.37 - 0.54) 1993 Modelled IHME
0.48 (0.40 - 0.58) 1992 Modelled IHME
0.53 (0.44 - 0.64) 1991 Modelled IHME
0.58 (0.47 - 0.71) 1990 Modelled IHME
1.1 (0.70 - 1.50) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.38 (0.24 - 0.49) 2019 Modelled Dugan et al., 2021
People who inject drugs (PWID)
Download
Value (%) Year Type Source
54.82 2015 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
66.67 2014 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
55.6 2013 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
59.63 2012 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
62.36 2011 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
48.7 2010 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
43.46 2009 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
44.87 2008 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
42.63 2006 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
43.28 2005 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
44.19 2004 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
35.83 2003 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
40.8 2002 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
37.9 2001 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
40.1 2000 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
51.7 1999 Survey/reported EMCDDA; Therapy Center for Dependent Individuals (KETHEA)
63.5 2016 Survey/reported EMCDDA
61.52 2015 Survey/reported EMCDDA
68.71 2014 Survey/reported EMCDDA
65.57 2013 Survey/reported EMCDDA
70.29 2012 Survey/reported EMCDDA
69.61 2015 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
73.45 2014 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
74.4 2013 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
73.42 2012 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
69.35 2011 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
69.3 2010 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
64.26 2009 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
55.46 2008 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
66.02 2006 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
61.72 2005 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
61.18 2004 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
67.2 2003 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
62 2002 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
67.9 2001 Survey/reported EMCDDA; Greek REITOX Focal Point (EKTEPN) &University Mental Health Research Institute (UMHRI).
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
66.5 2017 Survey/reported EMCDDA
National
Download
Value (%) Year Type Source
2.2 (1.30 - 3.40) 2010 Survey/reported Drositis et al, 2013
1.9 (0.50 - 2.60) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
65.7 (61.80 - 69.50) 2014 Modelled Degenhardt L et al, 2017
68.1 (65.50 - 70.60) 2013 Survey/reported EMCDDA
66.5 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
60,222 (49,155 - 73,424) 1990 Modelled IHME
55,438 (45,551 - 66,983) 1991 Modelled IHME
51,171 (42,686 - 61,541) 1992 Modelled IHME
47,539 (39,782 - 57,147) 1993 Modelled IHME
44,966 (37,379 - 53,897) 1994 Modelled IHME
43,861 (36,282 - 52,755) 1995 Modelled IHME
43,654 (36,080 - 52,303) 1996 Modelled IHME
43,536 (35,991 - 52,315) 1997 Modelled IHME
43,523 (35,790 - 52,216) 1998 Modelled IHME
43,527 (35,719 - 52,416) 1999 Modelled IHME
43,637 (35,618 - 52,760) 2000 Modelled IHME
45,408 (37,523 - 55,106) 2001 Modelled IHME
49,322 (40,618 - 59,978) 2002 Modelled IHME
53,989 (44,383 - 66,252) 2003 Modelled IHME
58,067 (47,899 - 71,772) 2004 Modelled IHME
60,180 (49,233 - 75,101) 2005 Modelled IHME
60,702 (49,583 - 75,366) 2006 Modelled IHME
61,011 (49,745 - 75,452) 2007 Modelled IHME
61,230 (50,108 - 75,444) 2008 Modelled IHME
61,429 (50,313 - 75,441) 2009 Modelled IHME
61,623 (50,629 - 75,364) 2010 Modelled IHME
61,718 (50,716 - 75,598) 2011 Modelled IHME
61,602 (50,603 - 75,776) 2012 Modelled IHME
61,443 (50,466 - 75,655) 2013 Modelled IHME
61,425 (50,480 - 75,833) 2014 Modelled IHME
61,560 (50,214 - 76,029) 2015 Modelled IHME
62,374 (51,080 - 77,154) 2016 Modelled IHME
63,162 (51,405 - 77,762) 2017 Modelled IHME
63,239 (51,733 - 77,155) 2018 Modelled IHME
63,040 (51,357 - 77,202) 2019 Modelled IHME
132,000 (82,000 - 169,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
8,500 (5,300 - 10,900) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.84 (2.96 - 4.85) 2019 Modelled IHME
3.78 (2.95 - 4.73) 2018 Modelled IHME
3.67 (2.84 - 4.57) 2017 Modelled IHME
3.63 (2.81 - 4.53) 2016 Modelled IHME
3.55 (2.76 - 4.45) 2015 Modelled IHME
3.49 (2.70 - 4.37) 2014 Modelled IHME
3.46 (2.68 - 4.35) 2013 Modelled IHME
3.4 (2.64 - 4.33) 2012 Modelled IHME
3.27 (2.54 - 4.19) 2011 Modelled IHME
3.15 (2.45 - 4.01) 2010 Modelled IHME
3.09 (2.41 - 3.95) 2009 Modelled IHME
3 (2.33 - 3.84) 2008 Modelled IHME
2.94 (2.29 - 3.80) 2007 Modelled IHME
2.81 (2.18 - 3.65) 2006 Modelled IHME
2.78 (2.15 - 3.61) 2005 Modelled IHME
2.77 (2.14 - 3.58) 2004 Modelled IHME
2.79 (2.16 - 3.61) 2003 Modelled IHME
2.79 (2.17 - 3.62) 2002 Modelled IHME
2.83 (2.20 - 3.66) 2001 Modelled IHME
2.86 (2.22 - 3.70) 2000 Modelled IHME
2.9 (2.22 - 3.75) 1999 Modelled IHME
2.92 (2.23 - 3.77) 1998 Modelled IHME
2.95 (2.26 - 3.84) 1997 Modelled IHME
3.01 (2.28 - 3.93) 1996 Modelled IHME
3.06 (2.32 - 3.99) 1995 Modelled IHME
3.13 (2.35 - 4.08) 1994 Modelled IHME
3.21 (2.42 - 4.21) 1993 Modelled IHME
3.29 (2.48 - 4.31) 1992 Modelled IHME
3.27 (2.46 - 4.31) 1991 Modelled IHME
3.28 (2.47 - 4.31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
397 (306 - 502) 2019 Modelled IHME
393 (306 - 492) 2018 Modelled IHME
384 (297 - 478) 2017 Modelled IHME
382 (296 - 476) 2016 Modelled IHME
376 (292 - 472) 2015 Modelled IHME
373 (289 - 467) 2014 Modelled IHME
373 (289 - 470) 2013 Modelled IHME
371 (288 - 473) 2012 Modelled IHME
361 (280 - 462) 2011 Modelled IHME
349 (271 - 445) 2010 Modelled IHME
344 (267 - 439) 2009 Modelled IHME
334 (259 - 427) 2008 Modelled IHME
327 (255 - 423) 2007 Modelled IHME
314 (243 - 407) 2006 Modelled IHME
310 (240 - 403) 2005 Modelled IHME
309 (239 - 399) 2004 Modelled IHME
311 (241 - 402) 2003 Modelled IHME
312 (242 - 405) 2002 Modelled IHME
315 (245 - 408) 2001 Modelled IHME
317 (246 - 411) 2000 Modelled IHME
321 (246 - 414) 1999 Modelled IHME
321 (246 - 415) 1998 Modelled IHME
322 (247 - 420) 1997 Modelled IHME
327 (248 - 427) 1996 Modelled IHME
330 (251 - 431) 1995 Modelled IHME
336 (252 - 438) 1994 Modelled IHME
342 (257 - 448) 1993 Modelled IHME
347 (262 - 456) 1992 Modelled IHME
342 (258 - 451) 1991 Modelled IHME
341 (257 - 448) 1990 Modelled IHME
527 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (15 - 28) 2019 Modelled IHME
21 (15 - 28) 2018 Modelled IHME
21 (15 - 28) 2017 Modelled IHME
21 (14 - 28) 2016 Modelled IHME
20 (14 - 27) 2015 Modelled IHME
20 (14 - 27) 2014 Modelled IHME
20 (14 - 27) 2013 Modelled IHME
20 (14 - 27) 2012 Modelled IHME
20 (14 - 27) 2011 Modelled IHME
20 (14 - 27) 2010 Modelled IHME
20 (14 - 27) 2009 Modelled IHME
20 (14 - 27) 2008 Modelled IHME
20 (14 - 26) 2007 Modelled IHME
19 (14 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (14 - 25) 2004 Modelled IHME
19 (14 - 25) 2003 Modelled IHME
19 (13 - 25) 2002 Modelled IHME
19 (13 - 25) 2001 Modelled IHME
19 (13 - 25) 2000 Modelled IHME
19 (13 - 25) 1999 Modelled IHME
19 (14 - 25) 1998 Modelled IHME
19 (14 - 26) 1997 Modelled IHME
19 (14 - 26) 1996 Modelled IHME
19 (14 - 26) 1995 Modelled IHME
19 (14 - 26) 1994 Modelled IHME
19 (14 - 26) 1993 Modelled IHME
19 (14 - 26) 1992 Modelled IHME
20 (14 - 26) 1991 Modelled IHME
20 (14 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
76 2017 Survey/reported EMCDDA, 2019
53 (43 - 65) 2014 Survey/reported Reitox National Focal Point, 2014
76 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
65 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
NSP in at least one prison
No
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
372
2019
(299 - 463)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
397
2019
(306 - 502)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
76
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources